Pabriga, Jenny .
HRN: 06-82-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2024
CEFUROXIME 500MG (TAB)
05/02/2024
05/08/2024
PO
500
BID
UTI; NSVD
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes